Medical device company focused on developing treatments for neurovascular diseases using minimally invasive techniques.
Silk Road Medical, Inc. operates as a prominent medical device company based in the United States, specializing in innovative solutions for treating carotid artery disease. The company's flagship products are designed specifically for transcarotid artery revascularization procedures.
Central to Silk Road Medical's offerings is the ENROUTE Transcarotid Neuroprotection System, which facilitates direct access to the common carotid artery and initiates temporary blood flow reversal to minimize the risk of cerebral embolism during procedures. Complementing this system is the ENROUTE Transcarotid Stent System, featuring a self-expanding, self-tapering stent to ensure optimal vessel support and patency.
Silk Road Medical also provides the ENHANCE Transcarotid Peripheral Access Kit, essential for initial access to the carotid artery, and the ENROUTE 0.014 Guidewire, a critical tool for navigating and crossing lesions during interventional procedures. These comprehensive solutions underscore the company's commitment to advancing minimally invasive treatments for vascular conditions.
Established in 2007 and headquartered in Sunnyvale, California, Silk Road Medical continues to lead innovation in carotid artery disease management. With a focus on patient safety and procedural efficacy, the company remains dedicated to enhancing clinical outcomes and expanding treatment options for physicians world wide.